Blood Culture Diagnostic Techniques Compared for Human Brucellosis
By LabMedica International staff writers Posted on 16 Apr 2014 |

Image: Scanning electron micrograph of Brucella abortus (Photo courtesy of the Czech University of Life Science).
Isolation of the bacteria Brucella is the gold standard in the laboratory diagnosis of brucellosis and as the organism is intracellular, the number of circulating bacteria is usually low.
Three different blood culture methods, the lysis concentration (LC), clot culture and conventional Castaneda blood culture techniques, have been compared for the isolation rate and recovery time in the diagnosis of human brucellosis.
Microbiologists at the Shri B. M. Patil Medical College (Bijapur, Karnataka, India) performed blood cultures by LC, clot culture and conventional method in 169 patients who had antibody titers equal to or greater than 160 international units by the serum agglutination test (SAT).
For the conventional culture technique, the blood specimen was inoculated aseptically into the broth phase of Castaneda's biphasic medium consisting of brain heart infusion agar and broth with Brucella selective supplement (Hi-Media; Mumbai, India). For the LC technique, the mixtures centrifuged and the supernatant was discarded and the sediment was inoculated in the Castaneda's medium, instead of culture plate.
For the clot culture technique, the blood clot was preserved in the sterile screw capped plastic tube with glass beads after removal of serum was used for this method. The clot was disrupted by shaking the tubes on a shaker for 15 minutes and the disrupted clot was then inoculated in Castaneda's medium. The media were incubated at 37 °C with 10% carbon dioxide for a maximum of 30 days. Provisional confirmation and biotyping of the isolate was done by performing slide agglutination test using B. abortus and B. melitensis monospecific antisera (Murex Biotech; Dartford, UK).
Overall blood culture positivity was found to be 24.8% by conventional culture, 34.9% by clot method, and 43.1% by the lysis technique. The mean recovery time by lysis and clot culture techniques was significantly less than conventional method, resulting in an overall difference of nearly six and four days respectively.
The authors concluded that for the isolation of Brucella from blood specimen, LC method is better than conventional Castaneda's method as the isolation rate is high and the recovery time is less. Clot culture is a better option when a second blood sample cannot be obtained for culture. As lysis and clot culture techniques are sensitive, simple and inexpensive and yield earlier results, they can be adapted in the technically and economically deprived areas where automated systems are not feasible. The study was published on March 19, 2014, in the Journal of Laboratory Physicians.
Related Links:
Shri B. M. Patil Medical College
Hi-Media
Murex Biotech
Three different blood culture methods, the lysis concentration (LC), clot culture and conventional Castaneda blood culture techniques, have been compared for the isolation rate and recovery time in the diagnosis of human brucellosis.
Microbiologists at the Shri B. M. Patil Medical College (Bijapur, Karnataka, India) performed blood cultures by LC, clot culture and conventional method in 169 patients who had antibody titers equal to or greater than 160 international units by the serum agglutination test (SAT).
For the conventional culture technique, the blood specimen was inoculated aseptically into the broth phase of Castaneda's biphasic medium consisting of brain heart infusion agar and broth with Brucella selective supplement (Hi-Media; Mumbai, India). For the LC technique, the mixtures centrifuged and the supernatant was discarded and the sediment was inoculated in the Castaneda's medium, instead of culture plate.
For the clot culture technique, the blood clot was preserved in the sterile screw capped plastic tube with glass beads after removal of serum was used for this method. The clot was disrupted by shaking the tubes on a shaker for 15 minutes and the disrupted clot was then inoculated in Castaneda's medium. The media were incubated at 37 °C with 10% carbon dioxide for a maximum of 30 days. Provisional confirmation and biotyping of the isolate was done by performing slide agglutination test using B. abortus and B. melitensis monospecific antisera (Murex Biotech; Dartford, UK).
Overall blood culture positivity was found to be 24.8% by conventional culture, 34.9% by clot method, and 43.1% by the lysis technique. The mean recovery time by lysis and clot culture techniques was significantly less than conventional method, resulting in an overall difference of nearly six and four days respectively.
The authors concluded that for the isolation of Brucella from blood specimen, LC method is better than conventional Castaneda's method as the isolation rate is high and the recovery time is less. Clot culture is a better option when a second blood sample cannot be obtained for culture. As lysis and clot culture techniques are sensitive, simple and inexpensive and yield earlier results, they can be adapted in the technically and economically deprived areas where automated systems are not feasible. The study was published on March 19, 2014, in the Journal of Laboratory Physicians.
Related Links:
Shri B. M. Patil Medical College
Hi-Media
Murex Biotech
Latest Microbiology News
- Viral Load Tests Can Help Predict Mpox Severity
- Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
- Credit Card-Sized Test Boosts TB Detection in HIV Hotspots
- Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
- Portable Molecular POC System Rules Out UTIs in Just 35 Minutes
- POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques
- Rapid Diagnostic Test Slashes Sepsis Mortality by 39%
- Blood Culture Assay Enhances Diagnostic Stewardship Through Targeted Panel Selection
- Real-Time Genome Sequencing Detects Dangerous Superbug Causing Hospital Infections
- Diagnostic Test Accurately Detects Colorectal Cancer by Identifying Microbial Signature in Gut Bacteria
- Rapid Bedside Test Predicts Sepsis with Over 90% Accuracy
- New Blood Test Detects Up to Five Infectious Diseases at POC
- Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
- New Test Diagnoses Bacterial Meningitis Quickly and Accurately
- Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Channels
Clinical Chemistry
view channel
New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
A new clinical chemistry analyzer is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories.... Read more
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read moreMolecular Diagnostics
view channel
Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age
As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more
RNA Screening Test Could Detect Colon Polyps Before They Become Cancerous
Colorectal cancer has become a growing health crisis, especially as it increasingly affects younger adults in their 20s, 30s, and 40s, while screening rates remain low. Colorectal cancer is now the leading... Read more
New RT-LAMP Assay Offers Affordable and Reliable Pathogen Detection for Resource-Limited Settings
The high cost and logistical complexities associated with rapid, point-of-care tests have long hampered widespread access to molecular diagnostics, especially in low- and middle-income countries.... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer
Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more
Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes
Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read morePathology
view channel
Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels
Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more
New AI-Based Method Effectively Identifies Disease Phenotypes Using Light-Based Imaging
Precision medicine, where treatment strategies are tailored to a patient's unique disease characteristics, holds great promise for cancer therapy. However, identifying disease phenotypes, which are critical... Read more
AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care
Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read moreTechnology
view channel
Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation
Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Ultra-Sensitive Biosensor Based on Light and AI Enables Early Cancer Diagnosis
Cancer diagnosis is often delayed due to the difficulty in detecting early-stage cancer markers. In particular, the concentration of methylated DNA in the bloodstream during the early stages of cancer... Read moreIndustry
view channel
BD Biosciences & Diagnostic Solutions to Merge with Waters
BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) and Waters Corporation (Milford, MA, USA) have entered into a definitive agreement to combine BD's Biosciences & Diagnostic Solutions... Read more